GDP in the US: USP Chapter and Stimuli Article on MKT
Recommendation

22 October 2026
Good Distribution Practice of Active Substances for Human and Veterinary Medicinal Products
In the Pharmacopeial Forum, PF 49(2), a proposal for a revised USP General Chapter <1079.2> "Mean Kinetic Temperature in the Evaluation of Temperature Excursions During Storage and Transportation of Drug Products" and a Stimuli Article "The Use of Mean Kinetic Temperature and the Need of Allowable Excursion Limits for Climatic Zone IVb" were published.
The background is that the United States Pharmacopeia (USP) is proposing the inclusion of temperature excursion limits for climatic zone IVb. Currently, Chapter <1079.2> contains only temperature excursion limits for climatic zone II.
As already reported in February, both documents, the revised Chapter <1079.2> and the Stimuli Article, were pre-posted prior to their publication in the Pharmacopeial Forum. According to the USP, this was to allow stakeholders additional time for reading and understanding.
For a summary of the changes and contents, please have a look at our news archive.
The documents are available on PF Online. Comments can be submitted until 31 May 2023.
Related GMP News
30.09.2026European GDP Association Developments May through August 2026
30.09.2026Warehouse Temperature Excursions: What Does the FDA Expect?
30.09.2026Version 4.0 of the Swissmedic Document on Notifications of Changes Published
30.09.2026USA: Court Stops Warehouse Activities Following Persistent Insanitary Warehouse Conditions
30.09.2026GDP Non-Compliance Report: CAPA Measures must not only be Promised but also Implemented
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September


